P. Hugh R. Barrett - Publications, H-index & Citations

P. Hugh R. Barrett

University of Western Australia

65H指数

418论文数

1.4W被引数

收录论文 180

发表时间

PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin-treated patients with very high apolipoprotein(a) concentration

JOURNAL OF INTERNAL MEDICINE

IF9.2

2022-02-09

PREAI

Ying, Qidi; Chan, Dick C.; Pang, Jing; Marcovina, Santica M.; Barrett, Peter Hugh R.; Watts, Gerald F.

Unravelling lipoprotein metabolism with stable isotopes: tracing the flow

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2021-11-01

PREAI

Ying, Qidi; Chan, Dick C.; Barrett, P. Hugh R.; Watts, Gerald F.

Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose-response model

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2021-08-27

OAAI

Jadhav, Satyawan B.; Crass, Ryan L.; Chapel, Sunny; Kerschnitzki, Michael; Sasiela, William J.; Emery, Maurice G.; Amore, Benny M.; Barrett, P. Hugh R.; Watts, Gerald F.; Catapano, Alberico L.

PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein (a) particles in statin-treated patients with elevated lipoprotein(a)

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2020-06-01

PREAI

Watts, Gerald F.; Chan, Dick C.; Pang, Jing; Ma, Louis; Ying, Qidi; Aggarwal, Shashi; Marcovina, Santica M.; Barrett, P. Hugh R.

Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2019-08-08

OAAI

Ma, Louis; Chan, Dick C.; Ooi, Esther M. M.; Marcovina, Santica M.; Barrett, P. Hugh R.; Watts, Gerald F.

Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentration

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2019-07-01

PREAI

Ma, Louis; Chan, Dick C.; Ooi, Esther M. M.; Barrett, P. Hugh R.; Watts, Gerald F.

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein (a) Isoform Sizes and Background Cholesterol-Lowering Therapy 脂蛋白 (a) 颗粒的产生是不同载脂蛋白 (a) 亚型大小和背景降胆固醇治疗中血浆脂蛋白 (a) 浓度的决定因素

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2019-04-02

OAAI

Chan, Dick C.; Watts, Gerald F.; Coll, Blai; Wasserman, Scott M.; Marcovina, Santica M.; Barrett, P. Hugh R.

Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2018-12-13

PREAI

Ma, Louis; Waldmann, Elisa; Ooi, Esther M. M.; Chan, Dick C.; Barrett, Hugh P. R.; Watts, Gerald F.; Parhofer, Klaus G.

Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque

ATHEROSCLEROSIS

IF5.7

2018-08-01

PREAI

Ooi, Esther M. M.; Ellis, Katrina L.; Barrett, P. Hugh R.; Watts, Gerald F.; Hung, Joseph; Beilby, John P.; Thompson, Peter L.; Stobie, Paul; McQuillan, Brendan M.

Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2018-07-01

OAAI

Chan, Dick C.; Watts, Gerald F.; Somaratne, Ransi; Wasserman, Scott M.; Scott, Rob; Barrett, P. Hugh R.

Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR+/- and LDLR-/-) Yucatan Miniature Pigs

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2018-05-01

OAAI

Burke, Amy C.; Telford, Dawn E.; Sutherland, Brian G.; Edwards, Jane Y.; Sawyez, Cynthia G.; Barrett, P. Hugh R.; Newton, Roger S.; Pickering, J. Geoffrey; Huff, Murray W.

Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics

EUROPEAN HEART JOURNAL

IF35.6

2018-03-16

120

OAAI

Watts, Gerald F.; Chan, Dick C.; Somaratne, Ransi; Wasserman, Scott M.; Scott, Rob; Marcovina, Santica M.; Barrett, P. Hugh R.

Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development

EUROPEAN JOURNAL OF ENDOCRINOLOGY

IF5.2

2017-08-01

OAAI

Birzniece, Vita; Barrett, P. Hugh R.; Ho, Ken K. Y.

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin 混合型高脂血症中大和小密度低密度脂蛋白的代谢和蛋白质组学: 瑞舒伐他汀的影响

JOURNAL OF LIPID RESEARCH

IF4.1

2017-07-01

OAAI

Thongtang, Nuntakorn; Diffenderfer, Margaret R.; Ooi, Esther M. M.; Barrett, P. Hugh R.; Turner, Scott M.; Ngoc-Anh Le; Brown, W. Virgil; Schaefer, Ernst J.

Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

MOLECULAR SYSTEMS BIOLOGY

IF7.7

2017-03-02

156

OAAI

Mardinoglu, Adil; Bjornson, Elias; Zhang, Cheng; Klevstig, Martina; Soderlund, Sanni; Stahlman, Marcus; Adiels, Martin; Hakkarainen, Antti; Lundbom, Nina; Kilicarslan, Murat; Hallstrom, Bjorn M.; Lundbom, Jesper; Verges, Bruno; Barrett, Peter Hugh R.; Watts, Gerald F.; Serlie, Mireille J.; Nielsen, Jens; Uhlen, Mathias; Smith, Ulf; Marschall, Hanns-Ulrich; Taskinen, Marja-Riitta; Boren, Jan

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

CIRCULATION

IF38.6

2017-01-24

OAAI

Watts, Gerald F.; Chan, Dick C.; Dent, Ricardo; Somaratne, Ransi; Wasserman, Scott M.; Scott, Rob; Burrows, Sally; Barrett, P. Hugh R.

Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism

CURRENT OPINION IN LIPIDOLOGY

IF4.6

2016-12-01

OAAI

Chan, Dick C.; Barrett, P. Hugh R.; Watts, Gerald F.